Amanote Research
Register
Sign In
Letter: HBsAg Kinetics-Guided Interferon Therapy for Chronic Hepatitis D
Alimentary Pharmacology and Therapeutics
- United Kingdom
doi 10.1111/apt.13872
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Pharmacology
Gastroenterology
Date
January 2, 2017
Authors
C.-N. Kao
T.-H. Su
J.-H. Kao
Publisher
Wiley
Related search
Letter: HBsAg Kinetics-Guided Interferon Therapy for Chronic Hepatitis D - Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Interferon Alpha-2b Therapy in Chronic Hepatitis Delta
Hepatitis Monthly
Hepatology
Infectious Diseases
Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients
PLoS ONE
Multidisciplinary
A Limit of Current Interferon Therapy for Chronic Hepatitis Type B.
Acta Hepatologica Japonica
Hepatology
Levamisole and HBsAg Positive Chronic Persistent Hepatitis.
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
HBsAg Loss in Chronic Hepatitis B: Pointers to the Benefits of Curative Therapy
Hepatology International
Hepatology
Vitamin D-Binding Protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study
Asian Pacific Journal of Cancer Prevention
Usefulness of Two-Step Interferon Rebound Therapy for Refractory Chronic Hepatitis C.
Acta Hepatologica Japonica
Hepatology
Graves' Hyperthyroidism Showing Transient Hypothyroidism During Interferon Therapy for Chronic Hepatitis Type C
Endocrine Journal
Endocrinology
Metabolism
Diabetes
